Michael L Curtin

Author PubWeight™ 8.54^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors.	J Med Chem	2005	1.04
2	Trifluoromethyl ketones as inhibitors of histone deacetylase.	Bioorg Med Chem Lett	2002	0.99
3	Expression and functional characterization of recombinant human HDAC1 and HDAC3.	Life Sci	2004	0.93
4	Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.	J Med Chem	2002	0.85
5	Alpha-keto amides as inhibitors of histone deacetylase.	Bioorg Med Chem Lett	2003	0.82
6	7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors.	J Med Chem	2008	0.81
7	A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units.	Bioorg Med Chem Lett	2003	0.81
8	Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families.	J Pharmacol Exp Ther	2012	0.79
9	Thienopyridine urea inhibitors of KDR kinase.	Bioorg Med Chem Lett	2006	0.79
10	Heterocyclic ketones as inhibitors of histone deacetylase.	Bioorg Med Chem Lett	2003	0.78
11	Erratum: The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex.	Nat Chem Biol	2017	0.75